Viewing Study NCT05631002


Ignite Creation Date: 2025-12-25 @ 3:48 AM
Ignite Modification Date: 2025-12-26 @ 2:35 AM
Study NCT ID: NCT05631002
Status: UNKNOWN
Last Update Posted: 2022-11-30
First Post: 2022-11-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Chemical Shift Encoding-based Water-fat Magnetic Resonance Imaging in Spinal Tumors
Sponsor: Peking University Third Hospital
Organization:

Study Overview

Official Title: Chemical Shift Encoding-based Water-fat Magnetic Resonance Imaging in Spinal Tumors
Status: UNKNOWN
Status Verified Date: 2022-08
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Fat composition of the spinal tumors is positively correlated with classification and differential diagnosis of benign and malignant tumors.
Detailed Description: Chemical shift encoding-based water-fat magnetic resonance imaging (MRI) is a non-invasive method that provides quantitative information about the biochemical water-fat composition of bone marrow and skeletal muscle in vivo.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: